OAS (2′-5′-oligoadenylate synthetase) Inhibitors

2'-5'-oligoadenylate synthetase (OAS) signaling is a critical part of the innate immune response against viral infections. When a virus invades a cell, OAS proteins detect viral double-stranded RNA (dsRNA) as a foreign presence. Upon recognition of dsRNA, OAS becomes activated and catalyzes the synthesis of 2'-5'-linked oligoadenylates (2-5As). These 2-5As then activate RNase L, an endoribonuclease, which degrades both viral and cellular RNA, impeding viral replication. This pathway is essential for the early response to viral infection, limiting virus spread within the host.

OAS (2'-5'-oligoadenylate synthetase) inhibitors are a class of chemical compounds designed to modulate the activity of the enzyme 2'-5'-oligoadenylate synthetase, a key player in the cellular antiviral defense mechanism. OAS enzymes are part of the innate immune response and are responsible for detecting viral double-stranded RNA (dsRNA), which triggers a cascade leading to the degradation of viral and cellular RNA, thus impeding viral replication. The inhibitors of OAS act by interfering with this detection and signaling process, essentially aiming to modify the enzyme's ability to respond to viral presence. They achieve this either by directly binding to the active site of the OAS enzyme, thereby blocking its catalytic activity, or by mimicking the structure of its natural substrates or products, effectively competing with them and disrupting the normal function of the enzyme.